Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety Read more
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs Read more
CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques Read more
February 5, 2025 @ 12:00 am

OBN’s round table C-Suite Discussions are designed exclusively for senior leaders (C-Suite or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry.